• RESEARCH BRIEFINGS

The antibiotic fidaxomicin acts selectively on the bacterium Clostridioides difficile, a main cause of intestinal infections. Structural and biochemical experiments reveal a region in the enzyme RNA polymerase that can sensitize the pathogen to fidaxomicin, helping to explain the drug’s selective clinical activity.



Source link